LIPIODOL ULTRA FLUID LIQUID

Страна: Канада

Език: английски

Източник: Health Canada

Активна съставка:

IODINE (ETHIODIZED OIL)

Предлага се от:

GUERBET

АТС код:

V08AD01

INN (Международно Name):

ETHYL ESTERS OF IODISED FATTY ACIDS

дозиране:

380MG

Лекарствена форма:

LIQUID

Композиция:

IODINE (ETHIODIZED OIL) 380MG

Начин на приложение:

INTRACAVITARY

Броя в опаковка:

5ML/10ML

Вид предписание :

Ethical

Терапевтична област:

ROENTGENOGRAPHY

Каталог на резюме:

Active ingredient group (AIG) number: 0103970041; AHFS:

Статус Оторизация:

APPROVED

Дата Оторизация:

2017-07-13

Данни за продукта

_ _
_ _
_Page 1 of 24_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
LIPIODOL
® ULTRA FLUID
ETHIODIZED OIL INJECTION, HOUSE STD
Solution for injection, 38% w/w (380 mg iodine/g or 480 mg iodine/mL)
V08AE non-watersoluble X-ray contrast media
For professional use only
Guerbet
BP 57400
95943 Roissy CdG Cedex
France
Date of Preparation:
July 12, 2017
Submission Control No: 196107
_ _
_ _
_Page 2 of 24_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY PRODUCT INFORMATION
........................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
3
CONTRAINDICATIONS
...................................................................................................
4
WARNINGS AND PRECAUTIONS
.................................................................................
4
ADVERSE REACTIONS
...................................................................................................
7
DRUG INTERACTIONS
...................................................................................................
9
DOSAGE AND ADMINISTRATION
.............................................................................
10
OVERDOSAGE
................................................................................................................
12
ACTION AND CLINICAL PHARMACOLOGY
............................................................ 12
STORAGE AND STABILITY
.........................................................................................
12
DOSAGE FORMS, COMPOSITION AND PACKAGING
............................................. 12
PART II: SCIENTIFIC INFORMATION
..............................................................................
14
PHARMACEUTICAL INFORMATION
.........................................................................
14
CLINICAL TRIALS
................................................................